Every two months, the following associations: YR2I, ADIC, JeCCO, Stapa, ADELIH and Doc’Up, invite you to the Professionnal Breakfasts where you can meet people who left academia after their PhD: clinical research associates (attachés de recherche clinique), consultants, scientific communcation, journalism… The morning is divided in two parts, first two round tables, followed by a free time in order to discover more precisely the experience of each guest and discover new career opportunities after your PhD.
Here is the Planning for the year 2017-2018:
- Imagine : Tuesday October 10th 2017
- Curie : Wednesday December 6th 2017
- Pasteur : Thursday Ferbuary 8th 2018
- Cochin : Tuesday April 4th 2018
- Saint-Louis : Thursday May 31st 2018
After a PhD in pharmaco-oncology obtained in 2012 in Paris Descartes university, Amelie became a scientific writer for Kephren. She then followed a training of clinical research associate and became the regional responsible for Hospira. She finally obtained a medical science liaison job at Jazz Pharmaceuticals where she currently works.
Mark Livingstone obtained his Ph.D. in Biochemistry in 2011 and completed it with a MBA at HEC. He reached an extensive international experience at the interface between academic research and the commercialization of scientific discoveries. He is currently Director, European Accounts at Scientist.com, a business which builds private marketplaces that simplify the purchase of research services.
After he got phd in genetics at Paris Descartes University in 2006, during one year Laurent studied strategical management at HEC. After that he joined OTC Asset Management as a charge d’affaires before he founded SPRING Invest, an investment fund in retail, in 2015.
After obtaining her PhD at the CEA, Morgane followed an alternating training with Ozyme and UPMC in Health Marketing and a Master 2 in Sales Negotiations at UPMC. She then worked for 3 years as a sales engineer at Life Technologies and then became “Key Account Manager – consumables” at Thermo Fisher Scientific.
Thomas Ybert is the CEO and co-founder of DNA Script. He holds an engineering degree and a PhD from Ecole Polytechnique. Thomas spent 3 years in the biotechnology department at Sanofi R&D, where he developed a biotherapeutic production platform based on yeast technology. After 2 years spent in San Francisco Thomas came back to France to found DNA Script.
Registrations are now open: REGISTRATION FORM